Survival Increase Seen for Adults With Relapsed Ph+ ALL

TUESDAY, Jan. 18, 2022 -- Real-world data show steady improvement in overall survival (OS) for patients with Philadelphia-positive (Ph+) acute lymphoblastic leukemia (ALL) who experienced relapse after allogeneic hematopoietic cell transplantation...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news